Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 50.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 20.00 (40.00%)
Open: 60.00
High: 60.00
Low: 60.00
Prev. Close: 60.00
CLC Live PriceLast checked at -
Calculus VCT is an Investment Trust

To invest primarily in a diverse portfolio of VCT qualifying UK growth companies whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Circular and Notice of GM

17 Jul 2023 15:04

RNS Number : 2692G
Calculus VCT PLC
17 July 2023
 

Publication of Circular and Notice of General Meeting

 

Recommended Proposals to approve entry into a new

Performance Incentive Scheme with Calculus Capital Limited ("Related Party Transaction")

 

17 July 2023

Calculus VCT plc announces that a circular relating to a proposed new Performance Incentive Agreement, which is a related party transaction under the Listing Rules, has been approved by the Financial Conduct Authority and is being published today.

A copy of the Circular will be available for download on the Company's website https://calculuscapital.com/investment-opportunities/calculus-vct/investor-information/ from the date of this announcement up to and including the date of the General Meeting and for the duration of the General Meeting.

In addition, a copy of the Circular will shortly be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

A notice convening the General Meeting is set out at the end of the Circular which proposes a single Resolution to approve the Related Party Transaction. The General Meeting will be held immediately following the conclusion of the Company's Annual General Meeting scheduled for 12.00 p.m. on 21 August 2023 at 1 Warwick, 1 Warwick Street, London W1B 5LR.

 

The Circular is expected to be posted to Shareholders by 28 July 2023 and extracts from the Chairman's letter to Shareholders are set out below.

 

Enquiries:

Calculus Capital Limited, Manager

020 7493 4940

Madeleine Ingram/Francesca Rayneau

 

Beaumont Cornish Limited, Sponsor

020 7628 3396

Roland Cornish

Recommended proposals to enter into a new performance incentive agreement with the Company's manager, Calculus Capital Limited ("Calculus Capital")

The Directors' Report contained in the Company's published annual accounts for the year ended 28 February 2022 referred to the board of the Company ("the Board") having recognised that the existing performance fee arrangements with the Company's manager, Calculus Capital, were no longer compatible with the current strategy of the Company. The Board resolved to undertake a review of the existing arrangements, and comparable arrangements within the VCT market, and communicate any proposed changes in due course.

Following the conclusion of that process, I am writing to you to seek Shareholders' approval for a new performance incentive agreement with Calculus Capital, to replace the existing incentive agreement.

As further set out below, it is proposed that the existing arrangements, which permit incentive payments to be made only following the payment of dividends totalling 105p per Ordinary Share, be replaced with an incentive scheme based instead on the achievement of realised gains made through the sale of investments by the Company. For incentive payments to become due under the proposed arrangements, two total return hurdles must also be satisfied and no payment may be made to the extent it would cause either of those hurdles not to be met.

Description of existing performance incentive arrangements

Under the current arrangements, Calculus Capital would be entitled to receive a performance incentive payment equal to 20% of distributions made by the Company to Shareholders once those Shareholders have received distributions equal to 105p per share. Distributions for these purposes are defined as dividends paid in cash and the consideration paid by the Company, on a per share basis, where it buys back shares from its Shareholders.

These arrangements were conceived when the Company was in its early stages as a 'structured products' VCT under the joint management of Investec Structured Products as well as Calculus Capital and operating in a very different market, regulatory environment and with a different strategy and return profile. No performance incentive has been paid historically under these arrangements and the Board do not consider any payment to be achievable in the foreseeable future.

Description of proposed new performance incentive arrangements

Under the proposed new arrangements, the incentive fees are only payable to Calculus Capital if:

· the Company's cumulative realised investment gains are greater than its cumulative realised investment losses since inception;

· the total return to Shareholders, made up of net asset value ("NAV") per share and dividends per share paid, ("the Total Return") is positive over a rolling five-year performance period; and

· the Total Return for the year preceding any payment has increased by at least 4.5% from the NAV per share at the end of the previous year.

If all three conditions are met, a performance fee equal to 20% of the excess realised gains (less previous performance incentive payments made) is payable to Calculus Capital. Excess gains are calculated simply by subtracting realised losses made on the disposal or write off of investments by the Company from realised gains made on the disposal of investments by the Company.

By way of illustration, if the new performance incentive arrangements were to have been in place as at the date of this document, the Company would have achieved excess cumulative realised gains of £326,997. However, this would not have resulted in an initial performance payment to Calculus Capital of £65,400 (ie 20% for such excess realised gains) being due in respect of the period ended on 28 February 2023 since both of the Total Return conditions set out above were not met at the relevant times.

Rationale for the revised performance incentive arrangements The existing performance incentive fee arrangement has been substantively unchanged since 2010, having been conceived of when the Company was in its first years of operation, with a co-manager in the form of Investec Structured Products, and in a period when the regulatory landscape for VCTs was markedly different.

The purpose of any performance fee arrangement with a fund manager is to incentivise that manager to perform, to enable it to attract and retain key staff and to align the interests of the manager with those of investors. The existing arrangements are not achieving those goals and so it is the opinion of the Board that they need to be refreshed.

 

With that in mind, we have surveyed the market for other arrangements which we believe are well structured to achieve the above aims and consulted with leading market commentators on what they consider to be optimal in terms of providing protection and value for money for shareholders.

 

A key element of the proposed new arrangements is that performance incentive fees would only be paid out based on realised gains made on disposals. A common weakness of certain of the VCT performance fee structures we reviewed, in the Board's opinion, is where these are based simply upon unrealised "paper" gains.

 

By combining a requirement for overall positive returns, the achievement of a 4.5% value hurdle in the lead up to any calculation, and the important requirement that fees are only then payable where actual, realised gains exceed realised losses, the Board believe that the proposed arrangements ensure shareholders' position is well protected while allowing the manager to be appropriately incentivised.

 

Related Party Transaction

As Calculus Capital is the investment manager of the Company, the entry into the new performance incentive arrangements described above will constitute a related party transaction under the listing rules of the FCA (the "Listing Rules") (the "Related Party Transaction"). Accordingly, the approval of Shareholders for the Company's entry into the Related Party Transaction is required in accordance with Listing Rule 11.1.7(3).

 

John Glencross, as the chief executive of Calculus Capital and a non-independent director, did not take part in the Board's consideration of the proposed new arrangements, nor vote on the Board's decision to put the Related Party Transaction to Shareholders for their approval at the General Meeting.

 

A notice convening the General Meeting is set out at the end of this document which proposes a single Resolution to approve the Related Party Transaction. The General Meeting will be held immediately following the conclusion of the Company's Annual General Meeting scheduled for 12.00 p.m. on 21 August 2023 at 1 Warwick, 1 Warwick Street, London W1B 5LR.

 

The Board, which has been so advised by Beaumont Cornish Limited, the Company's Sponsor, considers the Related Party Transaction to be fair and reasonable insofar as the Company's shareholders are concerned. In providing its advice to the Board, Beaumont Cornish Limited has taken into account the Board's commercial assessment of the effects of Related Party Transaction.

 

Risk factors relating to the Related Party Transaction

If the Related Party Transaction is not approved by Shareholders, the existing performance incentive arrangements will continue. As noted above, the Board and Calculus Capital consider that it may be more difficult to recruit, retain and incentivise quality investment management personnel without an appropriate incentive scheme in place. This may affect the performance of Calculus Capital, which may in turn impact the performance of the Company's portfolio and, thereby, returns to Shareholders, as the ability to pay performance incentive fees is an important component of management returns payable to an investment manager and, accordingly, an investment executive's remuneration package for managing a venture capital portfolio.

Recommendations The Board are of the opinion that the Related Party Transaction to be proposed at the General Meeting is in the best interests of the Shareholders as a whole and unanimously recommends that you vote in favour of the Resolution.

The Board, with only the exception of John Glencross who is ineligible to vote his shares, intend to vote, in respect of their own holdings of 37,455 Ordinary Shares (representing 0.05% of the voting rights in the Company), in favour of the Resolution.

Under the Listing Rules, Calculus Capital as a related party is not entitled to vote on the Resolution to be proposed at the General Meeting to approve the Related Party Transaction. Calculus Capital does not hold any shares in the Company and has undertaken to take all reasonable steps to ensure that its associates shall not vote on the Resolution and to include procuring undertakings not to vote from its employees.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGNKOBKQBKDBOD
Date   Source Headline
24th Apr 20244:49 pmRNSTransaction in Own Shares
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report
22nd Sep 20231:03 pmRNSPublication of a Prospectus
21st Sep 20233:51 pmRNSAppointment of Auditor
7th Sep 20234:57 pmRNSTransaction in Own Shares
30th Aug 202311:28 amRNSStatement re Intention to Raise
25th Aug 20231:19 pmRNSIssue of Equity
21st Aug 20233:25 pmRNSAGM and GM Statement
21st Jul 202312:13 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20233:04 pmRNSPublication of Circular and Notice of GM
3rd Jul 20235:43 pmRNSMay 2023 NAV Announcement
30th Jun 20232:15 pmRNSAnnual Financial Report & Change in Year-End date
5th Apr 20234:52 pmRNSIssue of Equity
5th Apr 20232:40 pmRNSIssue of Equity
15th Mar 20232:45 pmRNSIssue of Equity
9th Mar 20235:31 pmRNSTransaction in Own Shares
9th Mar 20237:00 amRNSTransaction in Own Shares
16th Dec 20223:41 pmRNSIssue of Equity
9th Dec 20225:06 pmRNSNet Asset Value(s)
18th Oct 202211:45 amRNSHalf-year Report
21st Sep 20222:34 pmRNSPublication of a Prospectus
31st Aug 20221:11 pmRNSIssue of Equity
29th Jul 202212:05 pmRNSTotal Voting Rights
14th Jul 20222:48 pmRNSRESULTS OF ANNUAL GENERAL MEETING
30th Jun 20222:03 pmRNSIssue of Equity
29th Jun 20222:37 pmRNSDirector Declaration
29th Jun 202211:45 amRNSNet Asset Value(s)
10th Jun 20225:12 pmRNSTransaction in Own Shares
1st Jun 20227:00 amRNSAnnual Financial Report
5th Apr 202212:23 pmRNSIssue of Equity
22nd Mar 20221:40 pmRNSIssue of Equity
1st Feb 20223:59 pmRNSNet Asset Value(s)
17th Dec 20211:08 pmRNSShare allotment and Total Voting Rights
12th Nov 20214:30 pmRNSTransaction in Own Shares
25th Oct 202112:00 pmRNSHalf yearly unaudited financial report
13th Sep 202112:12 pmRNSPublication of a Prospectus
2nd Sep 202110:30 amRNSIssue of Equity
6th Aug 20212:57 pmRNSChange of Registered Office
30th Jul 20211:18 pmRNSIssue of Equity
8th Jul 20215:07 pmRNSResult of Annual General Meeting
30th Jun 20213:38 pmRNSIssue of Equity and Total voting rights
17th Jun 202110:58 amRNSUnaudited Net Asset Value as at 31 May 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.